The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Clinical SynthesisFull Access

Beyond Psychopharmacology: Emerging Psychosocial Interventions for Core Symptoms of Schizophrenia

Abstract

Psychiatrists who work with patients with severe mental illness often are more focused on diagnosis, medical management, and psychopharmacology than on psychosocial treatments. Furthermore, many psychosocial interventions that show great promise may not be available locally, making it harder for psychiatrists to recognize emerging trends. Finally, there has not been an update in the American Psychiatric Association’s Practice Guideline for the Treatment of Schizophrenia for many years, and the most recent Patient Outcomes Research Team (PORT) review of evidence-based psychosocial treatments for schizophrenia was published eight years ago. This article reviews a selection of psychosocial interventions that have shown success in treating some of the more vexing and persistent core schizophrenia symptoms that often continue despite optimal pharmacologic treatment; formerly these had been considered too risky or out of reach for psychosocial intervention. The interventions reviewed include cognitive-behavioral therapy for psychosis (CBTp), which aims to reduce distress and disability from psychotic symptoms; CBT and other behavioral interventions focused for comorbid posttraumatic stress syndrome; cognitive training (remediation) interventions that use computerized training programs to reduce the severity and consequence of cognitive impairment associated with schizophrenia; clubhouse and peer support models that address the social alienation and social defeat endemic to persons with severe mental illness; and supported employment interventions that are effective in helping patients get back to work in a competitive job environment. The interventions are reviewed with the needs of the prescribing mental health clinician in mind. Each intervention’s strengths and weaknesses are described, as well as their role in recovery-oriented treatment services.

This review provides an update on psychosocial interventions for patients with schizophrenia. There already are some excellent comprehensive reviews of all psychosocial interventions, along with recommendations based on level of evidence. It is not my intent here to repeat those reviews. I will try to provide the reader with a sense of the overall direction in which psychosocial treatment of schizophrenia has headed and then focus on four specific interventions in greater detail. The interventions covered are cognitive-behavioral therapy as used for the treatment of schizophrenia (CBT for psychosis, or CBTp); treatments for comorbid posttraumatic stress syndrome (PTSD) occurring in someone with a primary diagnosis of schizophrenia; peer and clubhouse models that counter the pernicious effects of social exclusion; supported employment interventions targeting individuals currently unemployed with the goal of rapid return to competitive employment; and cognitive training interventions (cognitive remediation) originally developed for treatment of patients with brain injury and adapted for schizophrenia with specific computerized software that helps strengthen areas of cognitive difficulties.

What are the common elements of these approaches? All are important cutting-edge interventions that have undergone rapid growth with an influx of new research. Not every evidence-based psychosocial intervention is included; some important evidence-based psychosocial interventions such as assertive community treatment or family psychoeducation are not covered here because they have not changed that much since the last major review of evidence-based psychosocial treatments (1). Other interventions are important yet only questionably effective. For example, motivational interviewing for dual diagnosis schizophrenia patients has some promise but lacks consistent evidence-based efficacy. Last, but by no means least, is that these interventions are all very much aligned with a recovery model of schizophrenia. These interventions share a common element of ambition, aiming to improve outcomes that were previously believed to be out of reach for those with schizophrenia. On a personal note, it would have been hard for me to imagine when I first began to specialize in schizophrenia in the 1980s that I would be writing a review of psychosocial interventions that aim to reduce psychotic symptoms with psychotherapy; that PTSD can be treated in schizophrenia without triggering catastrophic regression; that persistent cognitive symptoms are amenable to retraining using neuroplasticity models; that we can successfully counter social exclusion and alienation; and that we can help get patients who have been chronically unemployed back to meaningful work.

The Concept of Recovery and Recovery-Oriented Treatment Services

One of the sea changes in treatment of schizophrenia has been the embracing of the recovery model of mental illness. Although the concept of recovery in schizophrenia has been present for quite some time, it was not really taken seriously until fairly recently. Now, recovery-oriented treatment has entered mainstream psychiatry. Although it is not usually considered a psychosocial intervention in its own right, its underlying principles are a crucial backdrop to the success of many of the specific interventions discussed in this article.

The history of the recovery movement began in the chasm between two very different worlds. On one side of the chasm was the world of mainstream psychiatry in the 1980s, where the prognosis for schizophrenia was very grim and the possibility of “recovery” was, at best, considered naïve. For example, DSM-III text on diagnostic criteria stated, “A complete return to premorbid levels of functioning in individuals diagnosed with schizophrenia is so rare as to cast doubt upon the accuracy of the [schizophrenia] diagnosis.” On the other side of the chasm was a small cadre of rehabilitation specialists and advocacy groups who believed that a significant part of the problem in schizophrenia was stigma, social exclusion, and lack of opportunity. They believed that under the right circumstances, full recovery was possible for some, and that some opportunity for improvement was possible for all. Two events that marked a change in the overall acceptance of a recovery approach were the President’s New Freedom Commission on Mental Health and the Surgeon General’s 1999 (2) mental health. Both emphasized the validity and primacy of recovery-oriented principles. Those principles, articulated in a recent online publication by the Substance Abuse and Mental Health Services Administration (SAMHSA), are summarized in Table 1 (3). All of the psychosocial interventions reviewed here have benefited from the growth and acceptance of recovery principles and, in turn, follow these principles as a core part of their respective approaches (see Table 2).

Table 1. The 10 Components of Recovery-Oriented Servicesa

No.Component
1Self-directed
2Individualized and person-centric
3Empowerment
4Holistic
5Nonlinear
6Strength-based
7Peer support
8Respect
9Responsibility
10Hope

aSource: 2012 Substance Abuse and Mental Health Services Administration’s Working Definition of Recovery (3).

Table 1. The 10 Components of Recovery-Oriented Servicesa

Enlarge table

Table 2. Summary of Psychosocial Interventions Included in the Review and Their Key Recovery Principlesa

InterventionTreatment GoalKey Recovery Principle
CBT for schizophrenia (psychosis)Use of principles of CBT adapted for persons with schizophrenia, with the goal of reducing the distressing and disruptive symptoms identified by the patientVery strong emphasis on treatment plan following the patient's agenda, not vice versa
Trauma-based therapyIdentifying symptoms of coexisting psychological trauma in persons with other primary (non-PTSD) psychiatric diagnoses, and adapting standard evidence-based treatments for PTSD to address trauma symptoms safely and effectively in the presence of other psychiatric diagnosesDealing with trauma is often valued and needed, and patients are resilient, so these problems can and should be treated.
Cognitive remediationUse of principles of neuroplasticity for helping brain injuries now applied with patients with schizophreniaIt is possible to treat one of the most disabling of all symptoms.
Clubhouse and peer interventionsUse of principles of social inclusion and social networks to engage the patient in health, social, and work-related endeavors, with an emphasis on empowerment and individual choice within a context of social acceptanceAttainment of personal goals and health objectives through peer support and acceptance facilitates enduring changes.
Supported employmentRapid reengagement into work of “real” [competitive] jobs, not sheltered programs that might perpetuate disability syndromeSchizophrenia does not mean one cannot work in a job one wants.

aCBT, cognitive-behavioral therapy.

Table 2. Summary of Psychosocial Interventions Included in the Review and Their Key Recovery Principlesa

Enlarge table

Cognitive-Behavioral Therapy Adapted for Patients With Schizophrenia

Cognitive-behavioral therapy (CBT) was initially developed as a treatment for depression. Over time, the range of disorders and conditions amenable to CBT interventions has expanded, with schizophrenia being one of the last holdouts. The delay in studying CBT for schizophrenia was due, in part, to a longstanding belief that psychosis was not amenable to CBT-oriented treatment approaches (4). The situation has changed. It is now very clear that CBT can be effective for the treatment of schizophrenia, and adaptations for schizophrenia have resulted in a designation of a treatment platform known as “CBT for psychosis” (CBTp). In this section I cover some of the key milestones in the research on adaptation of CBT for the treatment of schizophrenia, some of the core techniques used in CBT as it is practiced when treating schizophrenia, and how CBTp differs from a medical model orientation of supportive psychotherapy often practiced.

Background for Emergence of CBTp as an Independent Evidence-Based Treatment

In the United States, treatment of schizophrenia is focused on the biological model of disease causation and treatment, the so-called “medical model.” The medical model is oriented to view schizophrenia as a brain disorder originating from latent neurobiological vulnerabilities. Likewise, symptoms of schizophrenia have traditionally been thought of as being amenable only to pharmacologic intervention. The point here is not to debate whether schizophrenia is a brain disorder, but to emphasize the predominant position of the medical model in informing many psychosocial interventions. A consequence of the medical model was the belief that only medication or other somatic therapies could improve core symptoms of schizophrenia and that core symptoms would not, and could not, respond to psychotherapy (5).

This traditional view of the secondary role of psychotherapy has been challenged by the emergence of a form of CBT modified for persons with schizophrenia. Starting in the 1980s, case reports originating from the United Kingdom described successful outcomes from initiation of CBT-oriented psychotherapy with patients who still exhibited ongoing positive symptoms of schizophrenia. The clinicians involved observed noticeable improvements in core psychotic symptoms. The success of these individual cases formed the impetus for further studies using CBT techniques and for modifying these techniques along the way to better address specific challenges arising from the person’s schizophrenia (68). These successes were then developed into formalized treatment manuals and books that were published in the 1990s (9). This literature marked the beginning of the designated branch of CBT that was focused on improving outcomes for patients with schizophrenia and other psychotic disorders and that has now been renamed CBTp.

This literature was met with intense skepticism. The skepticism was based on the assumption that psychotic symptoms would respond only to pharmacologic intervention (e.g., “You can never talk a patient out of her delusions”). This debate (occurring primarily in the United Kingdom in the 1990s) was the impetus for funding randomized controlled trails (RCTs), usually consisting of a comparison of about 15 to 20 sessions of CBTp given by a trained therapist versus a control condition. The earliest studies compared CBTp with treatment as usual. These studies showed that adding CBTp reduced psychotic symptoms over and above their reduction by usual care. The findings challenged the belief that psychotic symptoms are not amenable to verbal interventions and were encouraging enough to support further research in the efficacy and effectiveness of CBTp for schizophrenia. The next wave of studies compared CBTp with other types of psychotherapeutic interventions, controlling for nonspecific effects of therapy (10). This literature is now well established, and CBTp is considered a mainstream evidence-based psychosocial intervention. However, the availability of CBTp (and training in CBTp) in the United States continues to lag far behind that in the United Kingdom.

Components of a Formal Course of CBTp

A formal CBTp intervention is intended as a course of individual psychotherapy to be delivered by a CBTp-qualified therapist. The number of sessions is given in a flexible but time-limited period, usually between 15–20 sessions over a period of three to six months, with less frequent “booster” sessions allowed upon completion of the formal course of CBTp. In the United Kingdom and some other countries (but not the United States), a clinician has to complete a training program in CBTp to be qualified as a CBTp therapist. Most clinicians who train in CBTp start out already experienced in working with severe mental illnesses and then go on to get specialty training and ongoing supervision.

Eligibility for CBTp (U.K. Guidelines)

The major criterion for suitability for a course of CBTp is that the patient reports some kind of problem(s) and the willingness to discuss those problem(s) in therapy. The current U.K. National Institute for Health and Care Excellence (NICE) guidelines state that CBTp should be offered for any patient with schizophrenia who requests it. Of note, it is not necessary for the patient to agree to or even acknowledge the presence of a mental illness to be eligible for CBTp because the intervention is not based on a diagnostic or disease model of treatment.

Stages of a Formal Course of CBTp

There are several stages that are sequenced during the course of CBTp, which are summarized in the box below (11). These phases are hierarchical, but some flexibility is allowable based on the tempo (how fast or slow to go) and needs of the patient and the specific problems or symptoms that are the focus of the therapy.

KEY STAGES OF A CBTp COURSE OF THERAPYa

Developing a therapeutic alliance based on the patient’s perspective

Setting out a problem list based on the patient’s priorities

Normalizing and a perspective of psychosis as a continuum

Developing alternate explanations of schizophrenia symptoms

Reducing the impact of disruptive or distressing symptoms that may be drivers of some or all of the issues established in the problem list

Summarizing the course of the CBTp, along with a review of therapy progress and a review of relapse prevention strategies prior to the last therapy session

___________________

a CBTp, cognitive-behavioral therapy for psychosis

Developing a therapeutic alliance based on the patient’s perspective.

A therapeutic alliance is essential to any successful psychotherapy. What sets CBTp apart is how the therapy develops with regard to the patient’s ongoing symptoms. The approach involves collaboration without preconceived ideas and making genuine efforts to understand the person’s experiences and beliefs. One of the more striking differences between the CBTp and medical model orientations is that with CBTp, the therapist will be very interested in the specifics of the patient’s experience.

Establishing a problem list relying on goals of the patient, not the clinician.

The next step is to come up with a mutually agreed upon problem list, usually consisting of from three to five items. The problem list is “owned” by the patient; in other words, the therapist follows the patient’s lead rather than the other way around. The therapist can help clarify the nature of the problem list. It may take a few sessions, but by the end, the list will be finalized and will often be used to orient the agenda for the remaining sessions.

Normalizing psychosis on a continuum.

Early on in the development of CBTp (1991), Kingdon and Turkington described the crucial importance of a normalizing explanation for psychotic symptoms in using CBT for schizophrenia (12). Normalizing remains one of the cornerstones of a CBTp approach and is used throughout the course of treatment. The assumption is that most of the patient’s experiences can be seen as normal responses, to a greater or lesser extent. An example of normalizing the psychotic experience is framing those experiences as being on a continuum of response to stress rather than as an automatic sign of severe psychopathology. Another example involves the use of descriptive language; for example, if a patient keeps a knife in bed because of fear of intruders, in a CBTp context it is called a “safety behavior,” not “acting on paranoid delusions.”

Developing alternative explanations for symptoms.

It is important to note that CBTp does not insist on acceptance by the patient of a diagnosis of schizophrenia. An agreement can be reached between patient and therapist that treatment, both psychological and pharmacological, may be helpful to counter some of the ongoing problems and challenges that were identified in the problem list. Rather, CBTp explores and develops the patient’s own understanding of his or her symptoms. The goal is to find explanations of the patient’s experiences that are acceptable to both patient and clinician. The therapy aims to improve understanding of the psychosis using a vulnerability-stress model. Strengths and vulnerabilities are identified. The antecedent period is explored carefully, any pertinent stressors are elicited, and the possible effects of stress are discussed.

Developing a case formulation with the patient when appropriate.

Some but not all versions of CBTp use formulations. Formulations for CBTp can resemble those of CBT for depression, but if the patient has cognitive issues, the formulations may not be as complex or subtle. Formulations tend to be used for more persistent or pervasive beliefs, such as systematized delusions. A formulation is drawn up collaboratively, with the therapist taking care to ensure that neither the patient nor his or her family is blamed for the symptoms or the illness. The formulation may ultimately allow for a widening of perspective such that dysfunctional beliefs are better understood, and the patient may then be amenable to gentle challenges. Again, these formulations do not force acceptance of a medical model of disease causation, but they also do not oppose those explanations, especially if preferable to the patient.

Reducing the impact of positive symptoms.

The goal of CBTp is not to try to convince or force the patient to agree that he or she has symptoms of a mental illness. Rather, the goal is to reduce the severity of, or distress from, the symptoms regardless of whether the patient accepts a diagnostic “label.” This goal is illustrated by some of the following ways in which a CBTp therapist would work with delusions or hallucinations.

Delusions are appropriate targets because they are usually distressing or disruptive. One commonly used technique to start the formulation process is known as “peripheral questioning.” The clinician begins by asking a series of peripheral questions about the person’s belief system, with the goal of understanding how the patient arrived at his or her convictions (e.g., “How could others control your thoughts? What mechanism would they use?”). Peripheral questioning is linked with graded reality testing, which in turn can lead to the introduction of doubt and the generation of alternative hypotheses. Education about real-world issues can help the patient understand whether the assumptions made to support his or her belief system are possible (e.g., “Can microchips really be inserted without your knowledge? Wouldn’t it hurt? Or wake you up?”).

Distressing hallucinations can be treated even if the hallucinations do not go away. Patients often believe voices are all-powerful, but this belief can be gently debated, and patients may be able to be less overwhelmed if they can think of them as less powerful (13). Likewise, the content of voices can be usefully debated; for example, when the voices are making abusive statements, the accuracy of those statements can be debated. Often patients are deeply ashamed and embarrassed by the voice content and will avoid social interaction because of the possibility that others might hear what the voices are saying. Situations that trigger an increase in voice intensity can be identified, and improved coping strategies can be generated. Affective responses to the hearing of voices (usually anger and anxiety) are often linked to unhelpful behaviors that maintain and exacerbate the voices. Once this pattern is identified, patients can gradually learn to engage more constructively with the voices they hear.

Adapting CBTp Principles to Day-to-Day Work With Schizophrenia Patients

At the time of this review, in the United States, it is unlikely that patients with schizophrenia have access to fully trained CBTp therapists or that comprehensive training for CBTp delivery is easily available to clinicians. However, many of the principles of CBTp lend themselves to day-to-day work with patients. There are now many introductory textbooks available for interested readers, and courses in CBTp are also available at major psychiatric meetings such as those of the American Psychiatric Association or the Beck Institute in Philadelphia (www.beckinstitute.org/get-training/). Some of the advances in CBTp can also be used to improve the therapeutic relationship and quality of communication in day-to-day work with patients with schizophrenia. There is general consensus that an overall approach that follows many of the CBTp principles can be taught without the rigorous training required to complete a CBTp course of therapy (1417).

Table 3 reviews some of the key principles that can be adapted to day-to-day interactions with patients with schizophrenia. These are applicable across disciplines and can be useful for medication management, case management, nursing staff, and other mental health teams (18).

Table 3. Adapting Some Key Techniques of CBTp to Day-to-Day Clinical Interactions With Patientsa

Clinical SituationCBTp ApproachRationale for Use in Daily Interactions
Establishing a working alliancePrimary goal of all encounters is working alliance; keep an open mind toward patient’s perspective; try not to contradict; be curious; focus on positives as well as weaknesses; when making recommendations that are not readily accepted, acknowledge issue and allow for respectful “agree to disagree” stance.The quality of the therapeutic relationship is the most important initial goal. Moving too quickly to a symptom assessment without context can be perceived as abrupt or insensitive; better to try to maintain natural flow. Immediate dismissal of beliefs or concerns, even if psychotic, tends to alienate patients.
NormalizingNormalizing is a basic CBTp technique used to help the patient feel less estranged or humiliated. In normalizing, stress and sleep deprivation will often be referred to as causes of symptoms. Normalizing, when sincere and appropriate, lowers tension and improves flow of discussion.Medical model interactions often emphasize deficits and leave the patient feeling frightened and alone (e.g., “I know you feel in danger but it’s not true, it is just your illness”). May lead to alienation from the clinician.
Interview techniquesCommon interview techniques can provide better-quality information and are less likely to be alienating. Examples include guided discovery, Socratic questioning (without contradicting), and what have been called “Columbo”b style interview questions (e.g., “I don’t understand; how can someone get radioactivity into your air conditioner?”).These interview techniques allow for obtaining further history and information while avoiding a standoff based on the patient’s perception that the clinician is not interested or is not open -minded.
Agreeing on the root cause of the problemA CBTp approach tries as much as possible to support the patient’s personal model of the cause of the problem. For example, if an African American reports that “the police are trying to kill me because I am black,” one can acknowledge the perception in a general sense without colluding in the particular case (e.g., “I have no way of knowing about your situation, but I certainly am aware of this being a national problem”).A medical model is useful when it is a shared understanding of the problem. However, many patients disagree with having a psychiatric diagnosis such as schizophrenia and will be further alienated when a medical model approach insists on their having such a diagnosis. A CBTp approach can bypass diagnosis and focus on distressing symptoms.
Interest in personal meaning of symptomsA major aspect of CBTp is that clinicians are encouraged to be genuinely interested in the nature of the symptoms, even if they are overtly psychotic. This interest does not “feed” or “abet” the psychosis, but instead offers an opportunity for the patient to be heard.Clinicians should try to keep an open mind and can usually remain curious, and if asked to give an opinion, they can offer alternative opinions in a respectful, gentle manner.
OptimismA CBTp approach tends to be optimistic that many of the “core” schizophrenia symptoms are amenable to both psychotherapeutic and pharmacologic interventions.The medical model can be optimistic but tends to rely exclusively on pharmacologic interventions as the primary approach.

aCBTp, cognitive-behavioral therapy for psychosis.

b“Columbo” is the name of a TV show popular in the 1970s in which the main character was a detective named Columbo who was known for asking simple questions that seemed naïve but ultimately disclosed the crucial information needed to solve the case.

Table 3. Adapting Some Key Techniques of CBTp to Day-to-Day Clinical Interactions With Patientsa

Enlarge table

Reconsidering the Role of Trauma in the Treatment of Schizophrenia

There has recently been a reconsideration of the entire subject of the relationship between trauma and psychosis, their interaction, and the treatment of (psychological) trauma and psychosis. Before I discuss the specific psychosocial interventions that aim to address comorbid PTSD in persons with schizophrenia, let us step back and consider the changing landscape of this comorbidity’s epidemiology and course.

Childhood Trauma as a Risk Factor for Onset of Schizophrenia

There is growing recognition that certain kinds of childhood adversity and trauma are causal risk factors for the later onset of schizophrenia and other psychotic disorders. It is hard to describe just how much the current research findings have altered the understanding of schizophrenia from where it was a only few decades ago. A major federal initiative defined the 1990s as the “Decade of the Brain,” and this initiative reflected the firm belief that diseases such as schizophrenia were best explained as being inherently caused by biologic factors that had little to do with social environment. The research at the time did not find any causal relationship between environmental conditions in childhood and schizophrenia onset but did find a genetic relationship between family history of schizophrenia and schizophrenia risk that was independent of environmental factors. The classic family risk studies at the time found that most of the identifiable latent risk for future schizophrenia was from heritable genetic risk (19). Using case registry and adoption studies, researchers concluded that the schizophrenia risk “followed the DNA, not the home environment.” Although there remained a significant portion of risk of schizophrenia that was not explained, there was no obvious association between stressful childhood events (e.g., parental divorce) and future schizophrenia risk. Therefore, it was accepted that the origin of schizophrenia had little to do with psychological trauma during childhood. While childhood trauma was an important risk factor for many other psychiatric disorders, schizophrenia was not considered to be one of them.

Epidemiologic research methods are much more sophisticated now. The ability to detect environmental risk factors for schizophrenia has greatly improved with the use of larger population-based cohorts, more detailed surveys, and more sophisticated statistical methods. There now is a robust and growing literature showing that childhood trauma substantially increases the risk of psychosis and the likelihood of schizophrenia onset, and specific trauma events include sexual trauma, bullying, emotional abuse, parental loss, and neglect (20). While it is beyond the scope of this review to go into further detail on these studies, this research has provided a compelling impetus to reduce the likelihood of further trauma after onset of schizophrenia and to study psychosocial interventions that are focused on comorbid schizophrenia and PTSD.

Prevalence and Burden of Comorbid PTSD

Even if trauma is a risk factor prior to schizophrenia onset, one might wonder if the problems associated with schizophrenia eclipse those of PTSD symptoms. Cross-sectional surveys of adults with severe mental illness such as schizophrenia report much higher prevalence of PTSD among them, with estimates in the 40% range (21), compared with estimates of 7% to 12% in community samples of the general population (22, 23). As shown in Table 4 (2430), the reasons for the high comorbidities include antecedent risk factors, plus those arising after the onset of schizophrenia, such as traumatic memories of psychotic behaviors, traumatic events associated with receiving mental health services, and susceptibility to being victimized or incarcerated. Surveys of severe mental illness populations consistently show enormous increases in risk of being victims of violent and sexual offenses, relative to the general population (3133). The overall relationship between trauma prior to and trauma after the onset of schizophrenia is summarized in Table 5 (3436).

Table 4. How Trauma Exposure, Schizophrenia, and Comorbid PTSD Interact

Timing and Type of Trauma ExposureSource of Trauma Symptoms
Before onset of schizophrenia
Experience of neglect, violation, or humiliationAdverse childhood events, including sexual trauma, bullying, emotional abuse, parental loss, and neglect, are risk factors for schizophrenia onset (24, 25)
After onset of schizophrenia
Treatment relatedTrauma symptoms arising from actual or perceived abuse from mental health clinicians or treatment services (e.g., use of excessive force, humiliation, being made an object of ridicule) (2628)
Symptom relatedTrauma symptoms arising from memories of embarrassing or destructive behaviors that were part of the acute psychotic episode (29, 30)
Disease relatedIncreased vulnerability to predatory behavior (e.g., sexual trauma of women) or incarceration because of behaviors associated with mental illness

Table 4. How Trauma Exposure, Schizophrenia, and Comorbid PTSD Interact

Enlarge table

Table 5. Clinical Implications for Comorbid PTSD and Schizophrenia

Clinical TaskImplications for Treatment
Determine validity of trauma historyTrauma history is often valid despite presence of schizophrenia or other psychotic disorder; content of delusions or hallucinations may reflect actual events.
Assess trauma history and PTSD symptoms for all patients with schizophreniaClinicians should be aware of the prevalence of a trauma history and comorbid PTSD; although PTSD symptoms may overlap with schizophrenia symptoms (34), they might need to be handled differently (35). Clinicians should avoid forcing patients to reveal trauma too early but should also be willing to listen to the patient’s reports of trauma.
Separate symptoms of PTSD from symptoms of schizophreniaStudies have shown that PTSD symptoms can be distinguished from schizophrenia symptoms. Even if not immediately treated, PTSD can be acknowledged and the patient’s experience normalized; this may also help clarify limitations of antipsychotic efficacy.
Take steps to prevent iatrogenic PTSDPsychotic patients are at high risk of secondary PTSD arising from their psychotic experience or its treatment, especially experiences of disrespect, humiliation, and excessive coercion. Mental health services should focus on patient advocacy and staff training initiatives (26, 36).
Provide formal treatment of comorbid PTSD with evidence-based interventionsCommon elements are that the patient must be help-seeking and motivated to address PTSD symptoms. The interventions are similar to evidence-based interventions for uncomplicated PTSD but have been modified and adapted for patients with primary psychotic disorders (usually schizophrenia).

Table 5. Clinical Implications for Comorbid PTSD and Schizophrenia

Enlarge table

Clinical Implications for Comorbid PTSD and Schizophrenia

Before discussing specific psychosocial interventions targeting comorbid PTSD, I want to emphasize that the main point for the practicing psychiatrist is that both cognitive and exposure therapies are feasible for patients with schizophrenia. The notion that treating comorbid PTSD is too stressful and therefore will induce a psychotic relapse is not a reason by itself to withhold treatment of PTSD. The important caveat is that one must make sure that the individual is motivated to address the comorbid PTSD symptoms.

The epidemiology of comorbid PTSD as well as concerns about the stress of trauma-focused work have served as the impetus for interventions targeting mentally ill patients who exhibit symptoms of PTSD. Of note is that most of the relevant studies are not limited to patients with a primary diagnosis of schizophrenia but capture a broader range of diagnoses associated with severe and persistent mental illness.

Trauma interventions based on CBT and CBTp platforms.

The intervention that has been most tested was developed by Mueser and colleagues and is known as “cognitive restructuring.” It is based on a CBT model of trauma adapted for persons with serious mental illness. The cognitive restructuring technique helps the patient translate distressing feelings into specific thoughts about the origin of those feelings. Patients are taught to modify inaccurate thoughts that are not supported by evidence (“The sexual abuse that happened was my fault”) and to develop an action plan when the evidence is there (“My boyfriend is threatening and abusive”). Patients then are guided to address areas of traumatic thoughts that are part of their PTSD symptoms. Other standard techniques such as breathing and relaxation techniques are integrated into the program (24). The results have shown clear benefits of cognitive restructuring in reducing symptoms of PTSD without any indication that the intervention is too stressful or induces underlying symptoms. The intervention is fairly complex, consisting of introductory sessions followed by nine to 12 individual sessions with a trained and supervised therapist. Attempts to evaluate more basic, focused strategies using only three sessions seem to show benefits somewhere in between: not as robust as the benefits of the full cognitive restructuring intervention but probably better than treatment as usual, in which trauma symptoms are usually not actively evaluated or treated.

CBT with gradual exposure to imagery of trauma.

Another team of investigators has also been developing a structured treatment intervention that combines group and individual sessions. The group sessions cover anxiety, anger, social, and trauma management skills. These are followed by eight individual sessions that use exposure methods, which consist of “the patient and therapist work[ing] collaboratively to construct the imaginal exposure narrative. Imaginal exposure sessions [last] . . . approximately 60 to 90 minutes depending on the needs and abilities of the patient” (25). The individual component also includes debriefing and other stress safety checks to safeguard against exacerbation of the primary mental illness (26). Although this was a pilot study, the initial results were encouraging; of the 20 subjects entering this treatment, 13 completed (65%), and at three-month follow-up, 10 of 13 completers no longer met criteria for comorbid PTSD. There was no safety signal of increased symptoms of mental illness, although it is possible that the dropouts were concerned about the stress of the intervention.

Another large study in the Netherlands compared exposure therapy (ET) consisting of eight 90-minute sessions over 10 weeks with either a wait list control condition or another active intervention (see below). The first session was a case conceptualization between therapist and patient, which established a hierarchy of traumatic experiences. The exposure was imagining the trauma, and audio recording and homework were used between visits. The results showed that ET patients were statistically and clinically improved relative to the wait-list subjects: 28.3% of ET subjects were in full remission, compared with 6.4% of control subjects, and 56% no longer met diagnostic criteria for PTSD, compared with 27.7% of control subjects (all ps<.01) (27). In what is turning out to be a pattern, there was no evidence of any worsening of symptoms of mental illness with ET; in fact, a follow-up analysis of the psychiatric outcomes found that “any symptom exacerbation (PTSD, paranoia, or depression) tended to occur more frequently in the [control] condition [compared with active ET]” (28).

Eye movement desensitization and reprocessing (EMDR) for comorbid PTSD.

In the above study, the active intervention was the use of eye movement desensitization and reprocessing (EMDR). The EMDR group was given eight 90-minute sessions of treatment intervention over 10 weeks. The first session was the same as in the ET condition, with a case conceptualization between therapist and patient that established a hierarchy of traumatic experiences. Eye movements were applied as the dual-attention stimulus, and memories were processed between sessions two and eight. The results showed a pattern similar to that of the ET condition; 16.4% of EMDR subjects were in full remission, compared with 6.4% of persons in the control group (p=.1), and 60% no longer met diagnostic criteria for PTSD, compared with 27.7% in the control group (p<.001) (27).

Taken together, these results are very encouraging, but they also show the relative dearth of relevant studies despite the clinical magnitude of the problem. It seems reasonable to conclude by saying that there is no evidence to support the longstanding belief that treating comorbid PTSD is too risky among schizophrenia patients who want to get help with their PTSD symptoms. It also seems that many of the evidence-based interventions for uncomplicated PTSD (CBT, ET, and EMDR) can be modified and are effective for mentally ill patients.

Cognitive Training (Remediation) Targeting Cognitive Symptoms

Cognitive Dysfunction as a Target Symptom

Schizophrenia is a mental health condition characterized by broad impairments in cognition. Cognitive symptoms may or may not be identified in routine clinical practice but are almost always present in formal testing of cognition. Cognitive problems are present at the time of the initial diagnosis and continue through the course of illness. Cognitive functioning cannot be described as a single entity or test score; cognitive testing usually covers a range of cognitive domains (29). Because there are differences in cognitive abilities in the general population, the same is true for people with schizophrenia. The determination that cognitive dysfunction is a part of the disease itself is based on several converging lines of evidence: Cognitive difficulties predate onset of psychotic symptoms in individuals followed over time who later convert to schizophrenia; there are consistent findings of worse cognitive testing scores in schizophrenia samples than in samples of normal control peers matched for age and education; and cognitive dysfunction is enduring and relatively independent of the degree of psychotic symptoms at any point in time. As reviewed in the landmark paper by Green (30), relative to its detectability in a routine clinical visit, cognitive dysfunction accounts for a disproportionate amount of enduring disability in schizophrenia patients (34).

Origins of Cognitive Training (Remediation) Therapy

It is known that cognitive pathways are not fixed and immutable, but rather are able to adapt and change to compensate for central nervous system injury. The principles of neuroplasticity and the promoting of brain recovery through the use of programmatic training modules targeting cognitive functioning go back to the 1960s (35). Cognitive remediation was a general term that described training programs (usually administered as a computer program) that provided cognitive exercises to either directly improve one or more aspects of cognitive functioning or circumvent remaining cognitive problems. Interest in this kind of approach for schizophrenia was kindled in the 1990s by the greater recognition of the central role of cognitive dysfunction in schizophrenia as a pernicious but silent driver of disability (36). The 1990s also was a decade of rapid change in the personal computer, which made it much easier to modify and adapt remediation programs developed for brain trauma patients to schizophrenia patients. Early studies showed encouraging results (37) and marked the beginning of what is now a well-established treatment for schizophrenia. Almost by default, the term “cognitive remediation” was used for schizophrenia, as it had been for brain injury. However, more recently, Vinogradov and others have criticized the use of the word “remediation” to describe a wholesale category of these approaches with psychiatric diagnoses. Not only is “remediation” too narrow, it is not a good fit for a recovery-oriented treatment intervention. They have proposed replacing “cognitive remediation” with “cognitive training” as a preferred description (38).

Evolution of Cognitive Training

The first level of outcome is change in test scores of standard measures of cognition. Because there are practice effects from repeating cognitive tests before and after the cognitive training intervention, outcome research using cognitive testing has to be very careful with appropriate control conditions. In 2007, McGurk and colleagues published the first major review of cognitive remediation (cognitive training) in the American Journal of Psychiatry (39). That review found that cognitive training demonstrated the potential to improve cognition scores over and above practice effects. Although the magnitude of the benefit was modest and did not restore cognitive function back to “normal,” it was “something.” Compared with disappointments so far in finding effective pharmacologic interventions, “something” in cognitive training is a lot better than the “nothing” shown by pharmacologic interventions. The other major finding was that functional outcomes were much better when the intervention combined the computerized practice training with coaching given by a trained clinician, who then could help the patient with goals set out in a psychosocial rehabilitation program. A later meta-analysis by Wykes and colleagues published only four years later in the American Journal of Psychiatry (40) also identified the impact of linking the cognitive training exercises to other psychotherapeutic or psychosocial interventions. As might be expected in the formative years of a promising treatment, there were many differences in how these interventions were developed and tested, including type of software program, number of sessions, the goals of the training, and how the cognitive, symptom, and functional outcomes were measured. The main take-home point is that there is enough evidence to say that cognitive problems associated with schizophrenia, under the right circumstances, can be treated with a cognitive training platform that has its roots in parallel work in using neuroplasticity in the adult brain to counteract the cognitive losses associated with brain injury.

Current Status of Cognitive Training

As reviewed by Fisher and colleagues (41), several computer programs originally developed for brain injury or developmental disorders were then adapted to and recalibrated for patients with schizophrenia; other programs were designed specifically for schizophrenia. These cognitive training programs included Psychological Software Services’ CogRehab (42), Marker Software’s Cogpack (43), Medalia and Freilich’s neuropsychogical and educational approach to cognitive remediation (NEAR) (44), and Posit Science’s Brain Fitness Program (BFT) auditory module (45). It is beyond the scope of this review to compare these programs, but they vary in the specific domains that are the focus of the intervention, the amount of training time, and the quantity and quality of research into their use.

The difference in the software used is only one of many differences in how cognitive training is conducted. Other differences include the intensity (dose) of the exposure, the specific cognitive domains of interest, the level of integration with other psychiatric services, and whether the cognitive training has other (human!) therapies that make a combination “package.” Further differences include which test is used to measure cognitive changes and whether or not there are additional measures of possible “real-world” improvements above and beyond the cognitive test scores. It is beyond the scope of this review to go into all the details and variations; there are excellent reviews available for interested readers. Instead, I will discuss the variations that have been described and studied in the world of cognitive training.

There are variations in the way the intervention aims to improve cognitive outcomes. Strategies are sometimes divided into restorative or compensatory techniques or some combination of the two. “Restorative” means directly improving cognitive performance in areas of relative weakness. An example of a restorative approach is to use drill and practice for targeting the areas of greatest weakness and making them “stronger.” This is often accomplished with repeated practice sessions using software programs designed to work on those parts of cognition that are lagging. Analogously to a video game in which difficulty levels change automatically as the player improves, so too do the computer practice drills adapt to the relative accuracy of the patient’s responses. If successful, the drills enable the patient to “catch up” to be closer to his or her expected (premorbid) performance. “Compensatory” means teaching better “work-around” solutions for cognitive problems that are more fixed. An example of compensatory work is setting up structured written reminders for someone with significant working memory problems. In addition to these programs, others are trying to tackle the cognitive equivalent of problems in social cognition. As one might guess, social cognition software will focus on how to “read” nonverbal social cues and learn to respond in socially appropriate ways.

It should be noted that patients do not engage in these computerized training sessions in isolation; these programs can be tedious or taxing for anyone, let alone a person dealing with schizophrenia. Therefore, another important aspect in the evolution of cognitive remediation training has been an effort to improve the level of interest in or sustaining motivation associated with these exercises, a process sometimes referred to as “gameification.” Another variable in such programs is the extent to which there are “real life” face-to-face interactions with a trainer or cognitive therapist. Staff can provide personal support and encouragement. The therapist often provides the individualization of the cognitive support, helping the patient match any gains in cognitive tasks with real-world tasks and goals. Or, the training may be done individually but linked to group therapy work that can help patients address social cognition and other uses.

As mentioned, integrating cognitive training and other kinds of evidence-based psychosocial therapy seems to produce the greatest changes in functional outcomes with sustained improvements that continue for some time after the formal training has ended (40). Sometimes the cognitive training and rehabilitation work are integrated (46), and sometimes these components are given sequentially (47). The underlying rationale is that improved cognitive test scores are not meaningful without a reason to put one’s mind to use.

Cognitive Training and Medication Status

Although medications in general do not change cognitive functioning very much, in practice, certain medication-prescribing practices interfere with the effectiveness of cognitive training. The most important finding is that patients given medications that impair cognition, especially anticholinergics, show more cognitive dysfunction at baseline and a less favorable response to the cognitive training intervention than do patients who have not been exposed to a significant anticholinergic load (4851). Another related finding is that lower antipsychotic doses predict better response to cognitive work, so presumably the opposite is true in that excessive doses will also interfere with optimal cognitive training. Taken together, it seems that optimizing the antipsychotic regimen to get to the lowest maintenance antipsychotic dose, and thus lowering the anticholinergic burden, will improve the effectiveness of most if not all of the cognitive training interventions.

Challenges Ahead

The future of cognitive training depends on whether it can succeed in reversing (or even attenuating) the terrible impact that cognitive problems have on outcome. Such success will depend on several assumptions: that the cognitive problems associated with schizophrenia are not progressive and that, therefore, any cognitive gains are likely to endure after the intervention is over; that patients will find in themselves sufficient motivation to do the cognitive training; that the improvements will endure once the intervention is finished; that patients benefiting from training will have the opportunity to develop further and to put new learning to good use; and that there will be adequate investment in the entire rehabilitation process to better allow for meaning changes in the patient’s life trajectory.

The Clubhouse (Peer) and Supported Employment Models

Relationships and work are the scaffold of life and are addressed in this section on interventions targeting social and vocational recovery.

The Clubhouse (Fountain House) and Peer Support (WRAP) Models

The clubhouse model is the predecessor of peer-based interventions and is exemplified by Fountain House, whose history is described on its website: “The Fountain House traces its roots to the late 1940s at Rockland State Hospital in Orangeburg, New York. Six patients formed a group that met in a hospital ‘club room’ where they shared their stories, read, painted and participated in social functions. Soon after leaving Rockland, they joined together to re-create the respectful and supportive group they had formed in the hospital. . . . All believed they could offer each other support in life’s challenges and sustain their social community” (www.fountainhouse.org/about/history). Clubhouse models also can provide community outplacement to “real” work settings in companies that provide a supportive work environment and, in return, rely on the clubhouse to guarantee adequate staffing. This arrangement offers clubhouse members real work that is also shared with the others in the clubhouse community. This approach is known as transitional employment. Clubhouse models have been enormously successful in supporting important aspects of personal recovery such as a sense of contribution, personal growth, and inclusiveness.

The sense of community that has been part of the success of the clubhouse model (52) has also been an impetus for other peer support programs. One such program is known as Wellness Recovery Action Planning (WRAP). WRAP uses peers to help participants manage their own long-term illnesses whether or not they are also receiving traditional mental health services. In fact, WRAP peer educators are trained in using formal diagnoses or medical jargon. As an inherent part of the social inclusion aspect of the program, WRAP uses a group format that mixes coursework and personal narratives. The topics go beyond “mental illness” and encompass (as the program’s name implies) a broader range of health and wellness strategies (53, 54). The overall results of a study using a version of WRAP targeting physical health issues showed positive changes, reduction of anxiety and depression, along with some reduction in use of more traditional mental health services (54). From an evidence-based intervention perspective, clubhouse and peer models have been quite varied in their approaches and methods of service delivery, and even the most disseminated programs (e.g., Fountain House, WRAP) have not yet been adequately studied enough for definitive statements about them to be possible. Having said that, I should note that their shared attributes of social inclusion, respect, sanctuary, freedom of self-expression, and safety from the demands of formal treatment services are laudable, since there is widespread agreement among service users and mental health clinicians of the value of programs that can undo some of the damage caused by stigma and social exclusion (55, 56).

Before the Ascendency of Supported Employment Interventions

For most of us, work is much more than a way to make a living. Work (or its academic equivalent) is a major part of our identity, providing meaning, structure, context, and social status. Schizophrenia often begins around a time of key changes in responsibilities and expectations, with work and career challenges that are often crucial to successful adulthood. The timing of disease onset could not be any worse in terms of disrupting this part of adult development, and it should not be a surprise that under- and unemployment are the rule, not the exception, among those given a diagnosis of schizophrenia.

Previously, the mainstream view in psychiatry had been that schizophrenia is permanently disabling. Before research on supported employment showed otherwise, it seemed obvious that returning to a “real” job would rarely, if ever, happen for a person with schizophrenia. Furthermore, even if returning to work was theoretically possible, it was not worth exposing patients to the stress of the competitive workplace because the stress would easily trigger a relapse. Therefore, before the arrival of the supported employment (SE) model, almost all “rehabilitation” programs for schizophrenia took place under sheltered conditions. In other words, patients would often go to another location to learn, rehearse, or practice job skills. Often the rehabilitation agenda would be “one size fits all,” and there would not be much communication between the patient’s mental health team and the rehabilitation service. On some level, “failure,” meaning that the patient would not transition to a real job, was perfectly acceptable to the mental health team, simply because the risk of potential relapse with the addition of more responsibilities was just not worth it. It was not a surprise that many of these “vocational” programs were actually more directed to other goals such as leisure time management or socialization skills.

Fortunately, a small cadre of rehabilitation specialists did not see it this way. They believed that persons with severe mental illness were not destined to fail. They believed that lack of employment was not the same as lack of capacity for employment. Their efforts in programmatic development and evidence-based research over the last few decades have resulted in the recognition that SE programs can often help disabled, persistently ill patients achieve their goal of competitive paid employment (57, 58). There was enormous initial skepticism about the SE model, but its success has been replicated and it is now one of the accepted evidence-based psychosocial interventions. SE is now an accepted evidence-based practice whose aim is to help “people with [psychiatric] disabilities participate as much as possible in the competitive labor market, working in jobs they prefer with the level of professional help they need” (59). The key elements of the SE model are shown in Table 6 (60).

Table 6. Summary of Supportive Employment (SE) Intervention

ElementDescription
ApproachFor persons with a stated goal of working, SE helps them focus on obtaining competitive employment. The SE approach encourages prompt engagement in active job searches, rather than engaging in extended preparation for work. SE staff provide guidance and support to the patient after starting a job, up to and including guidance and support in case of job loss, for as long as the patient wishes to continue with the SE intervention.
TheoryThe presence of a severe mental illness does not preclude capacity for obtaining and retaining employment. The patient determines the level and extent of SE engagement, and thus motivation for returning to work may be enhanced.
Key research findings
 Safety outcomesStudies of SE outcomes find no evidence that entering an SE program exacerbates symptoms or is associated with greater risk of relapse. Therefore, the theoretical risk of inducing stress-related symptom exacerbation is not supported.
 Efficacy outcomesA series of randomized controlled trials has evaluated the SE model by comparing it with more traditional rehabilitation programs, with the individual placement and support (IPS) model being the most studied (60). The results were summarized as follows in the 2009 Schizophrenia Patient Outcomes Research Team (PORT) (1): “50% or more persons obtained competitive employment at some point during the [SE] study follow-up period. Outcomes relating to the amount of hours worked and wages earned were also found to be superior among those receiving supported employment in comparison to those receiving traditional [sheltered] vocational services.”
 Additional outcomesSome of the more recent SE studies that have evaluated integration of SE with other interventions (e.g., cognitive retraining, substance abuse, first-episode) have found improvements in cognitive functioning, reduced substance abuse relapse, and better quality of life outcomes, respectively.
Limitations
 Success rateThe best outcomes show that a ceiling of about 50% of individuals going into SE will meet competitive employment criteria, but those criteria include part-time or temporary jobs.
 Duration of reemploymentSE interventions have not yet demonstrated the ability to help with sustained long-term employment or sustained economic independence for persons with schizophrenia.
 Best results require establishment of entire programStudies of subcomponents of the SE model have not been as effective as the entire integrated program, which increases the systems barriers to widespread dissemination.
 Lack of access to programs that follow the full SE modelImplementing the 2009 Schizophrenia PORT recommendation is not realistic given the paucity of fully staffed and trained SE model programs.

Table 6. Summary of Supportive Employment (SE) Intervention

Enlarge table

As summarized in the 2009 Schizophrenia Patient Outcome Research (PORT) recommendations, “At this point, about 50% of patients enrolled in these [SE] programs will return to competitive employment at some point [in the course of their rehabilitation]” (1, p. 51). The 2009 PORT recommendations also addressed and dismissed the concern that returning to work was too stressful and would worsen symptoms: “There is no evidence that [enrolling in an SE program] leads to … negative outcomes” (1). The progress made in SE is tempered by the relative lack of access to these services nationwide. Also, the SE outcomes speak to the continued challenges in helping patients with ongoing employment. Success in SE is generally limited to roughly one half of patients who start SE actually achieving any competitive employment for a set period of time. Furthermore, many of those who achieve competitive employment in the short run do not go on to sustained employment or economic self-sufficiency (61). Nonetheless, the current outcomes would not have been thought possible 25 years ago, so we can continue to be cautiously optimistic for even better outcomes for the next generation of rehabilitation interventions (62).

Summary

Many psychiatrists are not fully aware of the evolving nature of the psychosocial treatments outlined in this review. These treatments are ambitious in that they aim for kinds of outcomes that were not believed to be achievable a few generations back. These interventions also can address some vexing and persistent problems that are usually not amenable to pharmacologic interventions, including cognitive dysfunction, comorbid PTSD, social exclusion, and unemployment. Sadly, these interventions also share another common feature; they are not generally available and are generally not supported in a way that will ensure that most treatment centers will have access to these services or to clinicians trained and skilled in their delivery. However, they offer a message of hope that sustained social and vocational recoveries can and should be a part of our patients’ treatment plans.

Dr. Weiden is professor of Psychiatry, University of Illinois at Chicago, and chief medical officer, Uptown Mental Health, Uptown Research Institute, Chicago (e-mail: ).

The work was supported in part by the Katherine M. Ganaway Fund.

Dr. Weiden has served as a consultant to Allergen (Actavis), Alkermes, Delpor, Forum, Johnson & Johnson (Janssen Pharmaceuticals), Lundbeck, Otsuka, Novartis, Sunovion, Teva, and Vanda; he has received research support for clinical trials as investigator or subinvestigator at Uptown Research Institute from Actavis, Alkermes, Boehringer-Ingelheim, Forum, Intracellular, Johnson & Johnson (Janssen Pharmaceuticals), Neurocrine, Otsuka, Reckitt Benckiser Pharmaceuticals, and Takeda; he has participated in speakers bureaus for Alkermes, Forum, Johnson & Johnson (Janssen Pharmaceuticals), Lundbeck, Otsuka, and Sunovion; and he is a stockholder in Delpor, Inc.

References

1 Dixon LB, Dickerson F, Bellack AS, et al.: Schizophrenia Patient Outcomes Research Team (PORT): The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements. Schizophr Bull 2010; 36:48–70CrossrefGoogle Scholar

2 Satcher DS: Executive Summary: A Report of the Surgeon General on Mental Health. 1999.Google Scholar

3 SAMHSA's Working Definition of Recovery. Rockville, MD, Substance Abuse and Mental Health Services Administration, 2012. www.blog.samhsa.gov/2012/03/23/defintion-of-recovery-updated/#.VxuhcHpG_1lGoogle Scholar

4 Turkington D, Kingdon D, Weiden PJ: Cognitive behavior therapy for schizophrenia. Am J Psychiatry 2006; 163:365–373CrossrefGoogle Scholar

5 Drake RE, Sederer LI: The adverse effects of intensive treatment of chronic schizophrenia. Compr Psychiatry 1986; 27:313–326CrossrefGoogle Scholar

6 Garety PA, Kuipers L, Fowler D, et al.: Cognitive behavioural therapy for drug-resistant psychosis. Br J Med Psychol 1994; 67:259–271CrossrefGoogle Scholar

7 Garety P, Fowler D, Kuipers E, et al.: London-East Anglia randomised controlled trial of cognitive-behavioural therapy for psychosis. II: Predictors of outcome. Br J Psychiatry 1997; 171:420–426CrossrefGoogle Scholar

8 Tarrier N, Beckett R, Harwood S, et al.: A trial of two cognitive-behavioural methods of treating drug-resistant residual psychotic symptoms in schizophrenic patients: I. Outcome. Br J Psychiatry 1993; 162:524–532CrossrefGoogle Scholar

9 Kingdon DG, Turkington D: Cognitive-Behavioral Therapy of Schizophrenia. New York, Guilford Press, 1994Google Scholar

10 Turkington D, Sensky T, Scott J, et al.: A randomized controlled trial of cognitive-behavior therapy for persistent symptoms in schizophrenia: a five-year follow-up. Schizophr Res 2008; 98:1–7.CrossrefGoogle Scholar

11 Garety PA, Fowler D, Kuipers E: Cognitive-behavioral therapy for medication-resistant symptoms. Schizophr Bull 2000; 26:73–86CrossrefGoogle Scholar

12 Kingdon DG, Turkington D: The use of cognitive behavior therapy with a normalizing rationale in schizophrenia. Preliminary report. J Nerv Ment Dis 1991; 179:207–211CrossrefGoogle Scholar

13 McLeod T, Morris M, Birchwood M, et al.: Cognitive behavioural therapy group work with voice hearers. Part 2. Br J Nurs 2007; 16:292–295CrossrefGoogle Scholar

14 Turkington D, Kingdon D: Cognitive-behavioural techniques for general psychiatrists in the management of patients with psychoses. Br J Psychiatry 2000; 177:101–106CrossrefGoogle Scholar

15 Turkington D, Kingdon D, Turner T: Effectiveness of a brief cognitive-behavioural therapy intervention in the treatment of schizophrenia. Br J Psychiatry 2002; 180:523–527CrossrefGoogle Scholar

16 Malik N, Kingdon D, Pelton J, et al.: Effectiveness of brief cognitive-behavioral therapy for schizophrenia delivered by mental health nurses: relapse and recovery at 24 months. J Clin Psychiatry 2009; 70:201–207CrossrefGoogle Scholar

17 Turkington D, Munetz M, Pelton J, et al.: High-yield cognitive behavioral techniques for psychosis delivered by case managers to their clients with persistent psychotic symptoms: an exploratory trial. J Nerv Ment Dis 2014; 202:30–34CrossrefGoogle Scholar

18 Lencer R, Harris MSH, Weiden PJ, et al: When Psychopharmacology Is Not Enough: Using Cognitive Behavioral Therapy Techniques for Persons With Persistent Psychosis. Cambridge, MA, Hogrefe, 2011Google Scholar

19 Kendler KS, Diehl SR: The genetics of schizophrenia: a current, genetic-epidemiologic perspective. Schizophr Bull 1993; 19:261–285CrossrefGoogle Scholar

20 Bentall RP, de Sousa P, Varese F, et al.: From adversity to psychosis: pathways and mechanisms from specific adversities to specific symptoms. Soc Psychiatry Psychiatr Epidemiol 2014; 49:1011–1022CrossrefGoogle Scholar

21 Grubaugh AL, Zinzow HM, Paul L, et al.: Trauma exposure and posttraumatic stress disorder in adults with severe mental illness: a critical review. Clin Psychol Rev 2011; 31:883–899CrossrefGoogle Scholar

22 Kessler RC, Sonnega A, Bromet E, et al.: Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry 1995; 52:1048–1060CrossrefGoogle Scholar

23 Perkonigg A, Kessler RC, Storz S, et al.: Traumatic events and post-traumatic stress disorder in the community: prevalence, risk factors and comorbidity. Acta Psychiatr Scand 2000; 101:46–59CrossrefGoogle Scholar

24 Mueser KT, Gottlieb JD, Xie H, et al.: Evaluation of cognitive restructuring for post-traumatic stress disorder in people with severe mental illness. Br J Psychiatry 2015; 206:501–508CrossrefGoogle Scholar

25 Frueh BC, Grubaugh AL, Cusack KJ, et al.: Exposure-based cognitive-behavioral treatment of PTSD in adults with schizophrenia or schizoaffective disorder: a pilot study. J Anxiety Disord 2009; 23:665–675CrossrefGoogle Scholar

26 Frueh BC, Cusack KJ, Grubaugh AL, et al.: Clinicians’ perspectives on cognitive-behavioral treatment for PTSD among persons with severe mental illness. Psychiatr Serv 2006; 57:1027–1031CrossrefGoogle Scholar

27 van den Berg DPG, de Bont PAJM, van der Vleugel BM, et al.: Prolonged exposure vs eye movement desensitization and reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder: a randomized clinical trial. JAMA Psychiatry 2015; 72:259–267CrossrefGoogle Scholar

28 van den Berg DPG, de Bont PAJM, van der Vleugel BM, et al.: Trauma-focused treatment in PTSD patients with psychosis: symptom exacerbation, adverse events, and revictimization. Schizophr Bull 2015; 42:693–702CrossrefGoogle Scholar

29 Heinrichs RW: The primacy of cognition in schizophrenia. Am Psychol 2005; 60:229–242CrossrefGoogle Scholar

30 Green MF: What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry 1996; 153:321–330CrossrefGoogle Scholar

31 Dean K, Moran P, Fahy T, et al.: Predictors of violent victimization amongst those with psychosis. Acta Psychiatr Scand 2007; 116:345–353CrossrefGoogle Scholar

32 Darves-Bornoz J-M, Lempérière T, Degiovanni A, et al.: Sexual victimization in women with schizophrenia and bipolar disorder. Soc Psychiatry Psychiatr Epidemiol 1995; 30:78–84CrossrefGoogle Scholar

33 Brekke JS, Prindle C, Bae SW, et al.: Risks for individuals with schizophrenia who are living in the community. Psychiatr Serv 2001; 52:1358–1366CrossrefGoogle Scholar

34 Harvey PD, Green MF, Keefe RS, et al.: Cognitive functioning in schizophrenia: a consensus statement on its role in the definition and evaluation of effective treatments for the illness. J Clin Psychiatry 2004; 65:361–372CrossrefGoogle Scholar

35 Ben-Yishay Y, Gerstman L, Diller L, et al.: Prediction of rehabilitation outcomes from psychometric parameters in left hemiplegics. J Consult Clin Psychol 1970; 34:436–441CrossrefGoogle Scholar

36 Heinrichs RW, Zakzanis KK: Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology 1998; 12:426–445CrossrefGoogle Scholar

37 Medalia A, Aluma M, Tryon W, et al.: Effectiveness of attention training in schizophrenia. Schizophr Bull 1998; 24:147–152CrossrefGoogle Scholar

38 Keshavan MS, Vinogradov S, Rumsey J, et al.: Cognitive training in mental disorders: update and future directions. Am J Psychiatry 2014; 171:510–522CrossrefGoogle Scholar

39 McGurk SR, Twamley EW, Sitzer DI, et al.: A meta-analysis of cognitive remediation in schizophrenia. Am J Psychiatry 2007; 164:1791–1802CrossrefGoogle Scholar

40 Wykes T, Huddy V, Cellard C, et al.: A meta-analysis of cognitive remediation for schizophrenia: methodology and effect sizes. Am J Psychiatry 2011; 168:472–485CrossrefGoogle Scholar

41 Fisher M, Subramaniam K, Panizzutti R, et al.: Computerized cognitive training in schizophrenia: current knowledge and future directions; in Cognitive Impairment in Schizophrenia. Edited by Harvey PD. New York, Cambridge University Press, 2013CrossrefGoogle Scholar

42 Bracy O: PSSCogRehab (version 95). Indianapolis, Psychological Software Services, 1995Google Scholar

43 Marker KR: CogPack. Heidelberg and Ladenburg, Germany, Marker Software, 2007. www.markersoftware.comGoogle Scholar

44 Medalia A, Freilich B: The neuropsychological and educational approach to remediation (NEAR) model: practical principles and outcome studies. Am J Psych Rehab 2008; 11:123–143CrossrefGoogle Scholar

45 Fisher M, Holland C, Merzenich MM, et al.: Using neuroplasticity-based auditory training to improve verbal memory in schizophrenia. Am J Psychiatry 2009; 166:805–811CrossrefGoogle Scholar

46 McGurk SR, Mueser KT, Xie H, et al.: Cognitive enhancement treatment for people with mental illness who do not respond to supported employment: a randomized controlled trial. Am J Psychiatry 2015; 172:852–861CrossrefGoogle Scholar

47 Bowie CR, McGurk SR, Mausbach B, et al.: Combined cognitive remediation and functional skills training for schizophrenia: effects on cognition, functional competence, and real-world behavior. Am J Psychiatry 2012; 169:710–718CrossrefGoogle Scholar

48 McGurk SR, Green MF, Wirshing WC, et al.: Antipsychotic and anticholinergic effects on two types of spatial memory in schizophrenia. Schizophr Res 2004; 68:225–233CrossrefGoogle Scholar

49 Kern RS, Green MF, Marshall BD Jr, et al.: Risperidone versus haloperidol on secondary memory: Can newer medications aid learning? Schizophr Bull 1999; 25:223–232CrossrefGoogle Scholar

50 Minzenberg MJ, Poole JH, Benton C, et al.: Association of anticholinergic load with impairment of complex attention and memory in schizophrenia. Am J Psychiatry 2004; 161:116–124CrossrefGoogle Scholar

51 Vinogradov S, Fisher M, Warm H, et al.: The cognitive cost of anticholinergic burden: decreased response to cognitive training in schizophrenia. Am J Psychiatry 2009; 166:1055–1062CrossrefGoogle Scholar

52 Herman SE, Onaga E, Pernice-Duca F, et al.: Sense of community in clubhouse programs: member and staff concepts. Am J Community Psychol 2005; 36:343–356CrossrefGoogle Scholar

53 Cook JA, Copeland ME, Floyd CB, et al.: A randomized controlled trial of effects of Wellness Recovery Action Planning on depression, anxiety, and recovery. Psychiatr Serv 2012; 63:541–547CrossrefGoogle Scholar

54 Cook JA, Jonikas JA, Hamilton MM, et al.: Impact of Wellness Recovery Action Planning on service utilization and need in a randomized controlled trial. Psychiatr Rehabil J 2013; 36:250–257CrossrefGoogle Scholar

55 Morgan C, Burns T, Fitzpatrick R, et al.: Social exclusion and mental health: conceptual and methodological review. Br J Psychiatry 2007; 191:477–483CrossrefGoogle Scholar

56 Huxley P, Thornicroft G: Social inclusion, social quality and mental illness. Br J Psychiatry 2003; 182:289–290CrossrefGoogle Scholar

57 Marwaha S, Johnson S: Schizophrenia and employment - a review. Soc Psychiatry Psychiatr Epidemiol 2004; 39:337–349CrossrefGoogle Scholar

58 Crowther RE, Marshall M, Bond GR, et al.: Helping people with severe mental illness to obtain work: systematic review. BMJ 2001; 322:204–208CrossrefGoogle Scholar

59 Bond GR, Becker DR, Drake RE, et al.: Implementing supported employment as an evidence-based practice. Psychiatr Serv 2001; 52:313–322CrossrefGoogle Scholar

60 Becker DR, Drake BE: A Working Life for People With Severe Mental Illness. New York, Oxford University Press, 2003CrossrefGoogle Scholar

61 Harvey PD, Heaton RK, Carpenter WT Jr, et al.: Functional impairment in people with schizophrenia: focus on employability and eligibility for disability compensation. Schizophr Res 2012; 140:1–8CrossrefGoogle Scholar

62 Weiden PJ: Helping patients with mental illness get back to work. Am J Psychiatry 2015; 172:817–819CrossrefGoogle Scholar